Biogen price target lowered to $144 from $175 at Stifel
Stifel analyst Paul Matteis lowered the firm’s price target on Biogen (BIIB) to $144 from $175 and keeps a Hold rating on the shares. The ...
RBC Capital maintains S&P Global stock Outperform, $620 target
RBC Capital Markets sustained their optimistic stance on S&P Global (NYSE: SPGI) shares, reiterating an Outperform rating with a steady price target of $620.00. RBC Capital's analysis points to ...
DA Davidson lifts Confluent stock target to $42, keeps buy rating
DA Davidson analysts increased their price target on Confluent Inc (NASDAQ:CFLT) shares to $42.00, up from the previous ...